Kamari Pharma

Ness Ziona, Israel · Founded 2018 · Privately Held (backing)

Developer of a bio-pharmaceutical platform designed to develop proprietary small-molecule inhibitors. Kamari Pharma is based in Ness Ziona, Israel and was founded in 2018. Its last reported valuation was $42.8 million in Jun 2025. It has raised $48 million.

Last reported valuation
$42.8M
Oct 2026
Priced at
—
Total raised
$48.0M
Last round
—

Who backs Kamari Pharma?

5 investors
InvestorType
Arkin CapitalFamily office
Wille FinanceFamily office
BRM GroupAsset manager
Guangzhou Sino-Israel Bio-Industry Investment Fund—
Pontifax Venture Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kamari Pharma investors

5 investors are on record for Kamari Pharma, including Arkin Capital, Wille Finance, BRM Group and Guangzhou Sino-Israel Bio-Industry Investment Fund.

Free account
More of Kamari Pharma with a free account
  • ·Watch Kamari Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Kamari Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View